会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • N-PYRROLIDIN-3-YL-AMIDE DERIVATIVES AS SEROTONIN AND NORADRENALINE RE-UPTAKE INHIBITORS
    • N-吡咯烷-3-基酰胺衍生物作为丝氨酸蛋白酶和肾上腺素再摄取抑制剂
    • WO2004110995A1
    • 2004-12-23
    • PCT/IB2004/001943
    • 2004-06-07
    • PFIZER LIMITEDPFIZER INC.FISH, Paul, VincentFRAY, Michael, JonathanLOVERING, Deborah, JaneSTOBIE, AlanWAKENHUT, FlorianWHITLOCK, Gavin, Alistair
    • FISH, Paul, VincentFRAY, Michael, JonathanLOVERING, Deborah, JaneSTOBIE, AlanWAKENHUT, FlorianWHITLOCK, Gavin, Alistair
    • C07D207/14
    • C07D207/14
    • A compound of Formula (I) and pharmaceutically and/or veterinarily acceptable derivatives thereof, wherein R 1 is H, C 1 _ 6 alkyl, -C(X)Y, C 3 _ 8 cycloalkyl, aryl, het, aryl-C l _ 4 alkyl or het-C l _ 4 alkyl, wherein the cycloalkyl, aryl or het groups are optionally substituted by at least one substituent independently selected from C1_ 8 allkyl, C 1 _ 8 alkoxy, OH, halo, CF 3 , OCF 3 , SCF 3 , hydroxy-C l _ 6 alkyl, C 1 _ 4 alkoxy-C 1 _ 6 alkyl and C1_ 4 alkyl-S-C 1 _ 4 alkyl; R 2 is aryl or heteroaryl, each optionally substituted by at least one substituent independently selected from C 1 _ 8 alkyl, C 1 _ 8 alkoxy, OH, halo, CF 3 , OCF 3 , SCF3, hydroxy-C 1 _ 6 alkyl, C1_4alkoxy-C 1 _ 6 alkyl and C1_ 4 alkyl-S-C 1 _ 4 alkyl; R 3 is C 1 _ 6 alkyl, C 3 _ 8 cycloalkyl, C 3 _ 8 cycloalkyl-C 1 _ 6 alkyl, aryl, het, aryl-C l _ 4 alkyl or het-C 1 _ 4 alkyl, wherein the cycloalkyl, aryl or het groups are optionally substituted by at least one substituent independently selected from C 1 _ 6 alkyl, C 1 _ 6 alkoxy, OH, halo, CF 3 , OCF 3 , SCF 3 , hydroxy-C 1 _ 6 alkyl, C 1 _ 4 alkoxy - C 1 _ 6 alkyl and C 1 _ 4 alkyl-S­C 1 _ 4 alkyl; X is S or O; Y is H, C 1 _ 6 alkyl, aryl, het, aryl-C 1 _ 4 alkyl or het-C 1 _ 4 alkyl; and n is 1 or 2, provided that when n is 1, m is 0 or 1 and when n is 2, m is 0, wherein if m is 0, then * represents a chiral center. The compounds of the invention exhibit activity as both serotonin and noradrenaline re-uptake inhibitors and therefore have utility in a variety of therapeutic areas, for example urinary incontinence.
    • 式(I)化合物及其药学和/或兽医学上可接受的衍生物,其中R 1是H,C 1-6烷基,-C(X)Y,C 3-8环烷基,芳基,杂环基,芳基-C 1-4烷基或叔丁基-C 1-4烷基,其中 环烷基,芳基或苯基基团任选被至少一个独立地选自C 1-8烷基,C 1-8烷氧基,OH,卤素,CF 3,OCF 3,SCF 3,羟基-C 1-6烷基,C 1-4烷氧基-C 1-6烷基和C 1-4烷基-S-C 1-4烷基的取代基取代; R 2是芳基或杂芳基,各自任选被至少一个独立地选自C 1-8烷基,C 1-8烷氧基,OH,卤素,CF 3,OCF 3,SCF 3,羟基-C 1-6烷基,C 1-4烷氧基-C 1-6烷基和C 1-4烷基-S-C 1-4烷基的取代基取代; R 3是C 1-6烷基,C 3-8环烷基,C 3-8环烷基-C 1-6烷基,芳基,杂芳基,C 1-4烷基或叔丁基C 1-4烷基,其中环烷基,芳基或苯基基团任选被至少一个独立地选自C 1-6烷基,C 1-6烷氧基,OH, 卤素,CF 3,OCF 3,SCF 3,羟基-C 1-6烷基,C 1-4烷氧基-C 1-6烷基和C 1-4烷基-C 1-4烷基; X是S或O; Y是H,C 1-6烷基,芳基,杂环基,芳基-C 1-4烷基或叔丁基C 1-4烷基; n为1或2,条件是当n为1时,m为0或1,当n为2时,m为0,其中如果m为0,则*表示手性中心。 本发明的化合物表现出5-羟色胺和去甲肾上腺素再摄取抑制剂的活性,因此可用于各种治疗领域,例如尿失禁。